Scherl E - Search Results

1

Inflammatory bowel disease readmissions are associated with utilization and comorbidity.

Cohen-Mekelburg S, Rosenblatt R, Wallace B, Shen N, Fortune B, Waljee AK, Saini S, Scherl E, Burakoff R, Unruh M. Cohen-Mekelburg S, et al. Among authors: scherl e. Am J Manag Care. 2019 Oct;25(10):474-481. Am J Manag Care. 2019. PMID: 31622063 Free article.

2

Neuropeptide regulation of non-redundant ILC2 responses at barrier surfaces.

Tsou AM, Yano H, Parkhurst CN, Mahlakõiv T, Chu C, Zhang W, He Z, Jarick KJ, Zhong C, Putzel GG, Hatazaki M; JRI IBD Live Cell Bank Consortium; Lorenz IC, Andrew D, Balderes P, Klose CSN, Lira SA, Artis D. Tsou AM, et al. Nature. 2022 Nov;611(7937):787-793. doi: 10.1038/s41586-022-05297-6. Epub 2022 Nov 2. Nature. 2022. PMID: 36323781 Free PMC article.

3

Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results From the PIANO Registry.

Chugh R, Long MD, Jiang Y, Weaver KN, Beaulieu DB, Scherl EJ, Mahadevan U. Chugh R, et al. Am J Gastroenterol. 2024 Mar 1;119(3):468-476. doi: 10.14309/ajg.0000000000002553. Epub 2023 Oct 5. Am J Gastroenterol. 2024. PMID: 37796648

4

Diagnosis and Management of Cuffitis: A Systematic Review.

Hembree AE, Scherl E. Hembree AE, et al. Among authors: scherl e. Dis Colon Rectum. 2022 Dec 1;65(S1):S85-S91. doi: 10.1097/DCR.0000000000002593. Epub 2022 Aug 25. Dis Colon Rectum. 2022. PMID: 36399769

5

Increased Primary Bile Acids with Ileocolonic Resection Impact Ileal Inflammation and Gut Microbiota in Inflammatory Bowel Disease.

Battat R, Scherl EJ, Lukin D, Charilaou P, Mahtani P, Gerber J, Gandara JA; JRI IBD Live Cell Bank Consortium; Dündar F, Zumbo P, Betel D, Guo CJ, Longman RS. Battat R, et al. J Crohns Colitis. 2023 May 3;17(5):795-803. doi: 10.1093/ecco-jcc/jjac173. J Crohns Colitis. 2023. PMID: 36322790 Free PMC article.

6

Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation.

Arifuzzaman M, Won TH, Li TT, Yano H, Digumarthi S, Heras AF, Zhang W, Parkhurst CN, Kashyap S, Jin WB, Putzel GG, Tsou AM, Chu C, Wei Q, Grier A; JRI IBD Live Cell Bank Consortium; Worgall S, Guo CJ, Schroeder FC, Artis D. Arifuzzaman M, et al. Nature. 2022 Nov;611(7936):578-584. doi: 10.1038/s41586-022-05380-y. Epub 2022 Nov 2. Nature. 2022. PMID: 36323778 Free PMC article.

7

Management of Primary Sclerosing Cholangitis and Extraintestinal Disorders in Patients With Ileal Pouches: A Systematic Review.

Shen B, Yao Q, Scherl EJ. Shen B, et al. Among authors: scherl ej. Dis Colon Rectum. 2024 Jun 1;67(S1):S106-S114. doi: 10.1097/DCR.0000000000003231. Epub 2024 Feb 27. Dis Colon Rectum. 2024. PMID: 38411984

8

Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.

Chen K, Chen J, Smith E, Mathani P, Longman R, Lukin D, Scherl E, Gerber J, Battat R. Chen K, et al. Among authors: scherl e. Inflamm Bowel Dis. 2023 Sep 1;29(9):1499-1503. doi: 10.1093/ibd/izac236. Inflamm Bowel Dis. 2023. PMID: 36421052

9

The Cost-Effectiveness of Vedolizumab for Inflammatory Bowel Disease: A Review of the Current Literature.

Schneider Y, Saumoy M, Cohen-Mekelburg S, Steinlauf AF, Scherl EJ. Schneider Y, et al. Gastroenterol Hepatol (N Y). 2016 Oct;12(10):617-621. Gastroenterol Hepatol (N Y). 2016. PMID: 27917076 Free PMC article.

10

Reply.

Cohen-Mekelburg S, Schneider Y, Scherl E, Steinlauf A. Cohen-Mekelburg S, et al. Among authors: scherl e. Inflamm Bowel Dis. 2017 Mar;23(3):E14. doi: 10.1097/MIB.0000000000001032. Inflamm Bowel Dis. 2017. PMID: 28221253 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters